BE616646A
(ja)
|
|
|
|
|
DE1124485B
(de)
|
1960-02-12 |
1962-03-01 |
Hoechst Ag |
Verfahren zur Herstellung von analeptisch wirksamen Phenylcycloalkylmethylaminen
|
GB1420472A
(en)
*
|
1972-09-27 |
1976-01-07 |
Pfizer |
Aminophenyltetralin compounds
|
US4029731A
(en)
*
|
1974-11-06 |
1977-06-14 |
Pfizer Inc. |
Aminophenyltetralin compounds
|
US4045488A
(en)
*
|
1974-11-06 |
1977-08-30 |
Pfizer Inc. |
Aminophenyltetralin compounds
|
JPS52133905A
(en)
*
|
1976-04-30 |
1977-11-09 |
Sumitomo Chem Co Ltd |
Preparation of enamides
|
DE2963572D1
(en)
*
|
1978-04-11 |
1982-10-21 |
Ciba Geigy Ag |
Mercapto-imidazole derivatives, their preparation, mercapto-imidazole derivatives for the treatment of inflammatory diseases and their pharmaceutical compositions
|
US4556676A
(en)
*
|
1979-11-01 |
1985-12-03 |
Pfizer Inc. |
Antidepressant derivatives of trans-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
|
ZA817261B
(en)
|
1980-10-23 |
1982-09-29 |
Schering Corp |
Carboxyalkyl dipeptides,processes for their production and pharmaceutical compositions containing them
|
US4540690A
(en)
|
1982-02-09 |
1985-09-10 |
The Upjohn Company |
2-(Phenylmethylene)cycloalkylamines and -azetidines
|
JPS58177915A
(ja)
|
1982-04-12 |
1983-10-18 |
Green Cross Corp:The |
抗血栓剤
|
CA1244041A
(en)
|
1984-07-30 |
1988-11-01 |
Elijah H. Gold |
Process for the preparation of cis, endo- octahydrocyclopenta¬b|pyrrole-2-carboxylate
|
DE3431541A1
(de)
|
1984-08-28 |
1986-03-06 |
Hoechst Ag, 6230 Frankfurt |
Cis,endo-2-azabicycloalkan-3-carbonsaeure-derivate, verfahren zu deren herstellung, deren verwendung sowie zwischenprodukte bei deren herstellung
|
US4738709A
(en)
|
1985-01-10 |
1988-04-19 |
Ppg Industries, Inc. |
Herbicidally active substituted benzisoxazoles
|
US4634703A
(en)
*
|
1985-10-25 |
1987-01-06 |
Bristol-Myers Company |
Method for alleviation of panic disorders
|
US4687772A
(en)
*
|
1986-10-07 |
1987-08-18 |
Bristol-Myers Company |
Method for improvement of short term memory
|
US4777173A
(en)
|
1987-03-25 |
1988-10-11 |
Bristol-Myers Company |
Method for treatment of alcohol abuse
|
US4751231A
(en)
|
1987-09-16 |
1988-06-14 |
Merck & Co., Inc. |
Substituted thieno[2,3-b]pyrrole-5-sulfonamides as antiglaucoma agents
|
JPH01172388A
(ja)
|
1987-12-25 |
1989-07-07 |
Sumitomo Chem Co Ltd |
チエノ〔3,2−b〕ピロロ〔2,3−d〕ピロール類およびその製法
|
JPH01172388U
(ja)
|
1988-05-24 |
1989-12-06 |
|
|
US5468749A
(en)
*
|
1988-08-30 |
1995-11-21 |
Gawin; Frank H. |
Method for treatment of substance addiction
|
US4981870A
(en)
|
1989-03-07 |
1991-01-01 |
Pfizer Inc. |
Use of 4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine derivatives in the treatment of psychosis, inflammation and as immunosuppressants
|
JPH0347123A
(ja)
|
1989-05-05 |
1991-02-28 |
G D Searle & Co |
インドール―2―カルボキシレート化合物類を含有するcns疾患治療用組成物
|
ATE172712T1
(de)
|
1989-05-31 |
1998-11-15 |
Upjohn Co |
Zns-wirksame 8-heterocyclyl-2-aminotetralin derivate
|
IL97054A
(en)
|
1990-02-12 |
1995-10-31 |
Bristol Meyers Squibb Co |
Pharmaceutical preparations containing bospirone for the treatment of coma
|
US5086054A
(en)
|
1990-07-31 |
1992-02-04 |
Sri International |
Novel arylcycloalkanepolyalkylamines
|
JPH04327532A
(ja)
|
1991-01-31 |
1992-11-17 |
Bristol Myers Squibb Co |
活動過剰を伴う注意力欠乏疾患の治療に使用する医薬製剤
|
US5858407A
(en)
*
|
1992-02-27 |
1999-01-12 |
Alza Corporation |
Method for administering tandospirone
|
GB9208492D0
(en)
|
1992-04-16 |
1992-06-03 |
Glaxo Spa |
Heterocyclic compounds
|
KR100263428B1
(ko)
|
1992-10-28 |
2000-11-01 |
나카노 가쓰히코 |
신규한1,2-벤조이속사졸유도체또는그의염,및이를포함하는뇌보호제
|
GB9304500D0
(en)
|
1993-03-05 |
1993-04-21 |
Glaxo Spa |
Heterocyclic compounds
|
ES2081747B1
(es)
|
1993-09-07 |
1997-01-16 |
Esteve Labor Dr |
Amidas derivadas de tienopirroles, su preparacion y su aplicacion como medicamentos.
|
GB9321221D0
(en)
|
1993-10-14 |
1993-12-01 |
Glaxo Spa |
Heterocyclic compounds
|
GB9326284D0
(en)
|
1993-12-23 |
1994-02-23 |
Erba Carlo Spa |
Pyrrolydenemethyl-derivatives and process for their preparation
|
EP0738149B1
(en)
*
|
1994-01-10 |
2006-11-29 |
Teva Pharmaceutical Industries, Ltd. |
1-aminoindan derivatives and compositions thereof
|
CN1047384C
(zh)
|
1994-07-28 |
1999-12-15 |
北京大学 |
雷米普利的合成方法
|
PT779281E
(pt)
|
1994-08-30 |
2004-02-27 |
Sankyo Co |
Isoxazoles
|
US5484763A
(en)
|
1995-02-10 |
1996-01-16 |
American Cyanamid Company |
Substituted benzisoxazole and benzisothiazole herbicidal agents
|
US5554383A
(en)
*
|
1995-04-06 |
1996-09-10 |
Trustees Of Tufts College |
Veterinary method for clinically modifying the behavior of dogs exhibiting canine affective aggression
|
US5620997A
(en)
|
1995-05-31 |
1997-04-15 |
Warner-Lambert Company |
Isothiazolones
|
US5859042A
(en)
|
1995-09-27 |
1999-01-12 |
Ono Pharmaceutical Co., Ltd. |
Five membered heterocyclic compounds
|
GB9617990D0
(en)
*
|
1996-08-29 |
1996-10-09 |
Scotia Holdings Plc |
Treatment of pain
|
DE19711785A1
(de)
|
1997-03-21 |
1998-09-24 |
Merck Patent Gmbh |
Endothelin-Rezeptor-Antagonisten
|
WO1998050044A1
(en)
*
|
1997-05-07 |
1998-11-12 |
Algos Pharmaceutical Corporation |
Composition and method combining an antidepressant with an nmda receptor antagonist, for treating neuropathic pain
|
GB9717804D0
(en)
|
1997-08-22 |
1997-10-29 |
Zeneca Ltd |
Chemical compounds
|
AU9275498A
(en)
*
|
1997-10-03 |
1999-04-27 |
Chirotech Technology Limited |
Chiral amines
|
GB9803228D0
(en)
|
1998-02-17 |
1998-04-08 |
Zeneca Ltd |
Chemical compounds
|
GB9803226D0
(en)
|
1998-02-17 |
1998-04-08 |
Zeneca Ltd |
Chemical compounds
|
WO1999048868A2
(en)
|
1998-03-26 |
1999-09-30 |
Sugen, Inc. |
Heterocyclic classes of compounds for the modulating tyrosine protein kinase
|
US6500827B2
(en)
*
|
1998-05-08 |
2002-12-31 |
Pharmacia & Upjohn Company |
Drug combinations
|
US6476078B2
(en)
|
1999-08-11 |
2002-11-05 |
Sepracor, Inc. |
Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
|
US6632836B1
(en)
|
1998-10-30 |
2003-10-14 |
Merck & Co., Inc. |
Carbocyclic potassium channel inhibitors
|
GB9904786D0
(en)
*
|
1999-03-02 |
1999-04-28 |
Merck Sharp & Dohme |
Therapeutic agents
|
US6828460B2
(en)
|
1999-03-22 |
2004-12-07 |
Pfizer Inc. |
Resorcinol derivatives
|
US6245782B1
(en)
*
|
1999-05-17 |
2001-06-12 |
Heartdrug Research L.L.C. |
Methods of inhibiting platelet activation with selective serotonin reuptake inhibitors
|
FR2795733B1
(fr)
|
1999-06-30 |
2001-09-07 |
Aventis Pharma Sa |
Derives de streptogramines, leur preparation et les compositions qui les contiennent
|
DK1088824T3
(da)
|
1999-09-30 |
2004-04-13 |
Pfizer Prod Inc |
Bicykliske pyrrolylamider som glycogen phosphorylase inhibitorer
|
EP1391460A1
(en)
|
1999-09-30 |
2004-02-25 |
Pfizer Products Inc. |
Tricyclic pyrrolyl amides as glycogen phosphorylase inhibitors
|
JP4803935B2
(ja)
|
1999-10-08 |
2011-10-26 |
アフィニアム・ファーマシューティカルズ・インコーポレイテッド |
Fabi阻害剤
|
DE19960917A1
(de)
|
1999-12-17 |
2001-06-21 |
Bayer Ag |
Neue 3-Oxo-2,1-benzisoxazol-1(3H)-carboxamide zur Behandlung von ZNS-Erkrankungen
|
IN187170B
(ja)
*
|
2000-01-04 |
2002-02-23 |
Sun Pharmaceutical Ind Ltd |
|
US6632417B2
(en)
|
2000-03-07 |
2003-10-14 |
Chevron U.S.A. Inc. |
Process for preparing zeolites
|
JP2001247462A
(ja)
|
2000-03-07 |
2001-09-11 |
Otsuka Pharmaceut Co Ltd |
ウレアーゼ阻害剤
|
EP1136071A3
(en)
|
2000-03-22 |
2003-03-26 |
Pfizer Products Inc. |
Use of glycogen phosphorylase inhibitors
|
EP1188756B1
(en)
|
2000-04-19 |
2004-06-23 |
Kaneka Corporation |
Novel azetidine derivative and process for preparation thereof
|
GB0012214D0
(en)
|
2000-05-19 |
2000-07-12 |
Merck Sharp & Dohme |
Therapeutic agents
|
JP2002020291A
(ja)
|
2000-06-30 |
2002-01-23 |
Sumitomo Pharmaceut Co Ltd |
認知機能障害の治療剤
|
EP1307461A2
(en)
|
2000-08-04 |
2003-05-07 |
Eli Lilly And Company |
Substituted pyrrole compounds and their use as spla2 inhibitors
|
GB0021831D0
(en)
|
2000-09-06 |
2000-10-18 |
Astrazeneca Ab |
Chemical compounds
|
AU2000277557A1
(en)
|
2000-10-06 |
2002-04-22 |
Smith Kline Beecham Corporation |
Methods of agonizing and antagonizing fabk
|
TWI283575B
(en)
|
2000-10-31 |
2007-07-11 |
Eisai Co Ltd |
Medicinal compositions for concomitant use as anticancer agent
|
DE10063992A1
(de)
|
2000-12-21 |
2002-07-04 |
Max Planck Gesellschaft |
Tryptophan-Analoga in Proteinen, Peptiden und peptidischen Leitstrukturen
|
US6372919B1
(en)
|
2001-01-11 |
2002-04-16 |
Dov Pharmaceutical, Inc. |
(+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as an anti-depressant agent
|
US20020123490A1
(en)
|
2001-03-01 |
2002-09-05 |
Pfizer Inc. |
Combination treatment for anxiety, depression, obsessive compulsive disorder and psychosis
|
US20020183306A1
(en)
|
2001-05-30 |
2002-12-05 |
Pfizer Inc. |
Combination treatment for sleep disorders including sleep apnea
|
US7365205B2
(en)
|
2001-06-20 |
2008-04-29 |
Daiichi Sankyo Company, Limited |
Diamine derivatives
|
US6603000B2
(en)
*
|
2001-07-11 |
2003-08-05 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Synthesis for heteroarylamine compounds
|
BR0211565A
(pt)
|
2001-08-09 |
2004-06-29 |
Daiichi Seiyaku Co |
Derivados de diamina
|
US7045543B2
(en)
|
2001-11-05 |
2006-05-16 |
Enzrel Inc. |
Covalent conjugates of biologically-active compounds with amino acids and amino acid derivatives for targeting to physiologically-protected sites
|
US20030162825A1
(en)
|
2001-11-09 |
2003-08-28 |
Sepracor Inc. |
D-amino acid oxidase inhibitors for learning and memory
|
AU2002364517A1
(en)
|
2001-11-30 |
2003-06-17 |
Sepracor Inc. |
Tramadol analogs and uses thereof
|
KR100423875B1
(ko)
*
|
2001-12-06 |
2004-03-22 |
주식회사 포스코 |
키랄 아민의 제조 방법
|
TW200307539A
(en)
|
2002-02-01 |
2003-12-16 |
Bristol Myers Squibb Co |
Cycloalkyl inhibitors of potassium channel function
|
GB0205170D0
(en)
|
2002-03-06 |
2002-04-17 |
Astrazeneca Ab |
Chemical compounds
|
GB0205165D0
(en)
|
2002-03-06 |
2002-04-17 |
Astrazeneca Ab |
Chemical compounds
|
US6995144B2
(en)
|
2002-03-14 |
2006-02-07 |
Eisai Co., Ltd. |
Nitrogen containing heterocyclic compounds and medicines containing the same
|
AU2003227360A1
(en)
|
2002-04-25 |
2003-11-10 |
Yamanouchi Pharmaceutical Co., Ltd. |
Novel amide derivatives or salts thereof
|
WO2003092670A1
(en)
|
2002-05-03 |
2003-11-13 |
Warner-Lambert Company Llc |
Bombesin antagonists
|
JP2003335678A
(ja)
|
2002-05-17 |
2003-11-25 |
Sumitomo Pharmaceut Co Ltd |
神経因性疼痛治療薬
|
US7576204B2
(en)
|
2002-07-31 |
2009-08-18 |
Mercian Corporation |
Heterocyclic macrolide pharmaceutical agent, a method of producing the same and use of the same
|
ES2264534T3
(es)
|
2002-09-06 |
2007-01-01 |
Janssen Pharmaceutica N.V. |
Compuestos de tienopirrolilo y furanopirrolilo y su utilizacion como ligandos del receptor histaminico h4.
|
US8134029B2
(en)
*
|
2002-09-16 |
2012-03-13 |
Sunovion Pharmaceuticals Inc. |
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine
|
JP2006504693A
(ja)
|
2002-09-16 |
2006-02-09 |
セプラコア インコーポレーテッド |
トランス4−(3,4−ジクロロフェニル)−1,2,3,4−テトラヒドロ−n−メチル−1−ナフタレンアミンによるcns障害の治療
|
CN100584818C
(zh)
*
|
2002-09-16 |
2010-01-27 |
塞普拉科公司 |
用反式4-(3,4-二氯苯基)-1,2,3,4-四氢-1-萘胺及其甲酰胺治疗cns病症
|
US7087785B2
(en)
*
|
2002-09-16 |
2006-08-08 |
Sepracor Inc. |
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamide
|
JP2006504795A
(ja)
|
2002-10-03 |
2006-02-09 |
サイプレス バイオサイエンス, インコーポレイテッド |
神経学的障害を処置するための抗うつ剤の投薬量の段階的な漸増ならびに毎日の分割した投薬
|
US20040097554A1
(en)
|
2002-10-30 |
2004-05-20 |
Pfizer Inc |
Heteroaryl-hexanoic acid amide derivatives as immonomodulatory agents
|
WO2004041780A2
(en)
|
2002-11-07 |
2004-05-21 |
Pfizer Products Inc. |
N-(indole-2-carbonyl) amides as anti-diabetic agents
|
CN100434420C
(zh)
|
2003-01-31 |
2008-11-19 |
株式会社三和化学研究所 |
阻碍二肽基肽酶ⅳ的化合物
|
ATE467616T1
(de)
|
2003-04-11 |
2010-05-15 |
High Point Pharmaceuticals Llc |
Verbindungen mit aktivität an der 11beta- hydroxasteroiddehydrogenase
|
EP1633709A1
(en)
|
2003-04-30 |
2006-03-15 |
Pfizer Products Inc. |
Anti-diabetic agents
|
WO2004113345A1
(ja)
|
2003-06-20 |
2004-12-29 |
Japan Tobacco Inc. |
縮合ピロール化合物及びその医薬用途
|
ATE360638T1
(de)
|
2003-06-30 |
2007-05-15 |
Servier Lab |
Verfahren für die synthese von perindopril und seiner pharmazeutisch geeigneten salze
|
JP4745226B2
(ja)
|
2003-07-07 |
2011-08-10 |
チバ ホールディング インコーポレーテッド |
フロピロールの製造法
|
CA2534342C
(en)
|
2003-07-29 |
2016-05-10 |
V. Ravi Chandran |
Amino acid prodrugs
|
GB0318463D0
(en)
|
2003-08-07 |
2003-09-10 |
Astrazeneca Ab |
Chemical compounds
|
GB0319759D0
(en)
|
2003-08-22 |
2003-09-24 |
Astrazeneca Ab |
Chemical compounds
|
WO2005020986A1
(en)
|
2003-08-29 |
2005-03-10 |
Astrazeneca Ab |
Heterocyclic amide derivatives which posses glycogen phosphorylase inhibitory activity
|
GB0320422D0
(en)
|
2003-08-30 |
2003-10-01 |
Astrazeneca Ab |
Chemical compounds
|
US7396940B2
(en)
|
2003-10-23 |
2008-07-08 |
Hoffmann-La Roche Inc. |
Combinatorial library of 3-aryl-1H-indole-2-carboxylic acid
|
ES2282586T3
(es)
|
2003-11-19 |
2007-10-16 |
Les Laboratoires Servier |
Procedimiento de sintesis de perindopril y de sus sales farmaceuticamente aceptables.
|
EP1547997A1
(en)
*
|
2003-12-22 |
2005-06-29 |
Ppg - Sipsy |
New process for the synthesis of enamide derivatives
|
CA2552098A1
(en)
|
2003-12-29 |
2005-07-21 |
Sepracor Inc. |
Benzo[d]isoxazol-3-ol daao inhibitors
|
JP2007517056A
(ja)
|
2003-12-29 |
2007-06-28 |
セプラコア インコーポレーテッド |
ピロール及びピラゾールdaao阻害剤
|
EP1574498A1
(en)
*
|
2004-02-19 |
2005-09-14 |
PPG-Sipsy |
Process for the synthesis of substituted alpha-aminoindan derivatives
|
CA2559105A1
(en)
|
2004-03-16 |
2005-09-29 |
Janssen Pharmaceutica N.V. |
Benzisoxazoles
|
DE602005022062D1
(de)
|
2004-05-07 |
2010-08-12 |
Warner Lambert Co |
Als h3-liganden geeignete 3- oder 4-monosubstituierte phenol- und thiophenol-derivate
|
AU2005257859A1
(en)
|
2004-05-21 |
2006-01-05 |
Merck & Co., Inc. |
Amino cyclopentyl heterocyclic and carbocyclic modulators of chemokine receptor activity
|
EP1757591A4
(en)
|
2004-05-26 |
2010-05-05 |
Eisai R&D Man Co Ltd |
ZIMTSÄUREAMIDVERBINDUNG
|
WO2005123677A1
(en)
|
2004-06-16 |
2005-12-29 |
Actelion Pharmaceuticals Ltd |
4-carbonyl substituted 1,1,2-trimethyl-1a,4,5,5a-tetrahydro-1h-4-aza-cyclopropa'a!pentalene derivatives as agonists for the g-protein-coupled receptor s1p1/edg1 and immunosuppressive agents
|
CN1976938B
(zh)
|
2004-07-01 |
2012-08-15 |
第一三共株式会社 |
具有pde7抑制活性的噻吩并吡唑衍生物
|
US7276631B2
(en)
|
2004-07-20 |
2007-10-02 |
Bristol-Myers Squibb Company |
Cyclopentylamine and cyclohexylamine derivatives as NK-1/SSRI antagonists
|
JO2629B1
(en)
|
2004-08-19 |
2012-06-24 |
افينتيس فارما سوتيكالز انك |
Branched carboxylic acid amides containing thienobirol, carboxylic acid amides containing pyrolithiazole, and the like as kinase inhibitors casein epsilon
|
US20080262071A1
(en)
*
|
2004-09-17 |
2008-10-23 |
Timothy Dinan |
Pindolol for the Treating Premenstrual Syndrome and Premenstrual Dysphoric Disorder
|
JP2008527032A
(ja)
|
2005-01-19 |
2008-07-24 |
バイオリポックス エービー |
炎症の治療に有用なチエノピロール
|
CN100391945C
(zh)
|
2005-05-31 |
2008-06-04 |
浙江大学 |
一种s-(-)-吲哚啉-2-羧酸的合成方法
|
JP2009500425A
(ja)
*
|
2005-07-06 |
2009-01-08 |
セプラコア インコーポレーテッド |
エスゾピクロン及びトランス4−(3,4−ジクロロフェニル)−1,2,3,4−テトラヒドロ−n−メチル−1−ナフタレンアミン又はトランス4−(3,4−ジクロロフェニル)−1,2,3,4−テトラヒドロ−1−ナフタレンアミンの組み合わせ、並びに閉経期並びに気分、不安、及び認知障害の治療方法
|
FR2888506A1
(fr)
*
|
2005-07-12 |
2007-01-19 |
Cerenis Sa |
Utilisation de la 4-(3,4-dichloro-phenyl)-1,2,3,4- tetrahydro-naphtalen-1-ylamine pour le traitement du cancer
|
JP2009511462A
(ja)
|
2005-10-06 |
2009-03-19 |
メルク シャープ エンド ドーム リミテッド |
D−アミノ酸酸化酵素阻害剤として神経変性および精神疾患を治療するための縮合ピロールカルボン酸の使用
|
UA95788C2
(en)
|
2005-12-15 |
2011-09-12 |
Ф. Хоффманн-Ля Рош Аг |
Fused pyrrole derivatives
|
RU2430913C2
(ru)
|
2006-01-06 |
2011-10-10 |
Сепракор Инк. |
Циклоалкиламины в качестве ингибиторов повторного поглощения моноамина
|
JP5438975B2
(ja)
|
2006-01-06 |
2014-03-12 |
サノビオン ファーマシューティカルズ インク |
テトラロン系モノアミン再取り込み阻害剤
|
DK2013835T3
(en)
|
2006-03-31 |
2015-12-14 |
Sunovion Pharmaceuticals Inc |
Preparation of chiral amides and AMINES
|
KR20090015089A
(ko)
*
|
2006-05-31 |
2009-02-11 |
세프라코 아이엔시. |
트랜스 4-(3,4-디클로로페닐)-1,2,3,4-테트라하이드로-1-나프탈렌아민 및 그의 포름아미드에 의한 통증장애 치료방법
|
US7579370B2
(en)
|
2006-06-30 |
2009-08-25 |
Sepracor Inc. |
Fused heterocycles
|
US20080058395A1
(en)
|
2006-06-30 |
2008-03-06 |
Sepracor Inc. |
Fused heterocyclic inhibitors of D-amino acid oxidase
|
CA2659060A1
(en)
|
2006-06-30 |
2008-01-10 |
Sepracor Inc. |
Fused heterocyclic inhibitors of d-amino acid oxidase
|
US7884124B2
(en)
|
2006-06-30 |
2011-02-08 |
Sepracor Inc. |
Fluoro-substituted inhibitors of D-amino acid oxidase
|
CN1962656A
(zh)
|
2006-11-29 |
2007-05-16 |
沈阳药科大学 |
吲哚美辛5-氟尿嘧啶甲酯药用化合物及其制剂和制备方法
|
FR2909376A1
(fr)
*
|
2006-11-30 |
2008-06-06 |
Cerep Sa |
Procedes de preparation de la desmethulsertraline ou d'un de ses sels pharmaceutiquement acceptables
|
US7902252B2
(en)
|
2007-01-18 |
2011-03-08 |
Sepracor, Inc. |
Inhibitors of D-amino acid oxidase
|
EP2074092A2
(en)
|
2007-01-18 |
2009-07-01 |
Sepracor Inc. |
Inhibitors of d-amino acid oxidase
|
MX2009012685A
(es)
|
2007-05-31 |
2009-12-14 |
Sepracor Inc |
Cicloalquilaminas sustituidas con fenilo como inhibidores de la reabsorcion de monoamina.
|
WO2010017418A1
(en)
|
2008-08-07 |
2010-02-11 |
Sepracor Inc. |
Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase
|